Alissa K. Lipton

Partner

+1 617 646 1643 +1 617 646 1643
alissa.lipton@finnegan.com alissa.lipton@finnegan.com

Two Seaport Lane
Boston, MA 02210-2001

vCard

Show Alissa’s work in

Alissa Lipton focuses on trials and appeals and pre-litigation counseling involving a wide range of technologies, including biotechnology, pharmaceutical, and medical device patents. She has particular experience in litigation arising under the Hatch-Waxman Act and litigation relating to biologics.

Alissa is a registered patent attorney and has experience in matters before the U.S. Patent and Trademark Office (USPTO) as well as counseling and opinion work. She has been involved in cases in which the patents-at-issue were subject to co-pending proceedings before the USPTO.

Alissa was recognized as a Boston, Massachusetts, “Rising Star” by The National Law Journal and as an “Up and Coming Attorney” for Excellence in the Law by Massachusetts Lawyers Weekly. She frequently writes and presents on patent law topics relevant to the pharmaceutical and life sciences industries. Alissa is co-author of Court of Appeals for the Federal Circuit: Practice and Procedure. She is also a contributing author of Patent Litigation Strategies Handbook, published by the American Bar Association Section of Intellectual Property Law and Bloomberg BNA.

While in law school, Alissa was a member of the Harvard Journal of Law and Technology.

Et Cetera

Clerkship, U.S. Court of Appeals for the Federal Circuit, Honorable Alvin A. Schall, 2004-2005.

Experience

Represented Health Diagnostic Laboratories in litigation in a suit brought by an exclusive licensee relating to SLCO1B1 genetic tests for statin-induced myopathy.

1:13-cv-13111, D. Mass., Judges Bowler, Saylor, Talwani

Representing Eli Lilly and Company in Hatch-Waxman patent litigation relating to osteoporosis drug Forteo®.

1:16-cv-00596, Judges Pratt, Brookman

Represented Duchesnay in Hatch-Waxman litigation, defending against generic attack on Duchesnay's Diclegis® product.

1:14-cv-00912, D. Del., Judges Robinson, Fallon

Assisted ConforMIS in obtaining a successful settlement in a case relating to customizable knee implants.

1:12-cv-01109, D. Del., Judge Sleet

Defended MedImmune, LLC in patent infringement litigation brought by Novartis Vaccines and Diagnostics, Inc. concerning recombinant DNA expression vectors; case ultimately resolved through confidential settlement.

1:11-cv-00084, D. Del., Judges Robinson, Thynge

Represented Eli Lilly in district court and Federal Circuit in ANDA case on patent covering Strattera®, a treatment for ADHD. Prevailed on appeal at the Federal Circuit and patent held to be not invalid and infringed.

10-1500, -1520, -1521, -1522, -1523, -1524, Fed. Cir., Judges Lourie, Newman
2:07-cv-03770, D.N.J., Judges Cavanaugh, Dickson, Falk

2 more

Insights

Workshop

Life Sciences Workshop: Biotech Health Check—Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law

May 10, 2018

Workshop

Life Sciences Workshop: Updates and Recent Trends in Pharmaceutical and Biotechnology Patent Law

May 16, 2017

Event

Biologics and Biosimilars: Development with an Eye Towards FDA Approval

February 17, 2017

Reception

Federal Circuit Year in Review

January 11, 2017

Federal Circuit IP Blog

Federal Circuit Trends of 2016

December 29, 2016

Podcasts

Alissa Lipton and Jeffrey Jacobstein on Obviousness-Type Double Patenting

November 10, 2016

12 more

Professional Recognition

"Patent litigator Alissa K. Lipton is known for her exceptional legal writing and advocacy as well as for her pro bono work with veterans appealing disability denials. She has co-authored two widely-used publications, including a practice and procedure treatise for the U.S. Court of Appeals for the Federal Circuit.”